Cited by 70Menstrual Health and DisordersMaternal Mental Health During Pregnancy and PostpartumAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Medical (fluoxetine) and psychological (cognitive–behavioural therapy) treatment for premenstrual dysphoric disorder

Hunter, Myra S, Ussher, Jane M, Cariss, Margaret, Browne, Susannah, Jelley, Rosanne, Katz, Maurice·2002·Journal of Psychosomatic Research

Abstract

Objectives To investigate (i) the differential changes in premenstrual symptoms, mood, cognitions, and coping strategies during two treatments [cognitive-behavioural therapy (CBT) and fluoxetine] for premenstrual dysphoric disorder (PMDD) and (ii) the characteristics of those with good vs. poor outcome post treatment and at 1 year follow-up.Methods Premenstrual symptoms, mood (Hospital Anxiety and Depression Scale, HADS), causal attributions, and use of cognitive and behavioural coping strategies were examined during 6 months of both treatments. The two treatment groups were then combined and divided on the basis of good vs. poor outcome posttreatment and at 1 year follow-up. Baseline measures were used to predict posttreatment outcome, and baseline and posttreatment measures were examined when attempting to predict outcome at 1 year follow-up.Results Both treatments were equally effective at the end of 6 months (prospective daily diary measure). Fluoxetine treatment had a more rapid effect and greater impact upon anxiety symptoms, while CBT was associated with increased use of cognitive and behavioural coping strategies and a shift from a biomedical to a biopsychosocial causal attribution of premenstrual symptoms. Depressed mood at baseline assessment was associated with poorer response to both treatments, and learning active behavioural coping strategies was associated with a good outcome at 1 year follow-up.Conclusion These results provide evidence of differential treatment effects of fluoxetine and CBT for PMDD and offer information that will enhance clinical decision-making.

Integrity signals

Registry

Crossref · 10.1016/s0022-3999(02)00338-0

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hunter, M. S., Ussher, J. M., Cariss, M., Browne, S., Jelley, R., & Katz, M.
Affiliations
University College London (GB)
Corresponding author
Hunter, Myra S
Venue
Journal of Psychosomatic Research
Publisher
Elsevier BV
Published
2002-09
Volume
53
Issue
3
Pages
811-817
ISSN
0022-3999 (ISSN-L)
OpenAlex
W1574111772
Cited by
70
References
27
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 2 · 2013: 4 · 2012: 5
FWCI
2.10
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Psychosomatic Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • Health Service Executive
  • University College London
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
premenstrual dysphoric disorder, fluoxetine, cognitive behavioral therapy, premenstrual symptoms, coping strategies, causal attribution, biopsychosocial model, treatment outcome prediction, depressive mood, anxiety symptoms, treatment response
MeSH terms
Adaptation, Psychological, Administration, Oral, Adult, Anxiety Disorders, Female, Fluoxetine, Humans, Premenstrual Syndrome, Risk Factors, Cognitive Behavioral Therapy, Treatment Outcome, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review